Yearend report Camanio Care AB
|
|
- Randell Merritt
- 5 years ago
- Views:
Transcription
1 Yearend report Camanio Care AB January December 2017
2 Summary Figures in brackets relate to the corresponding period of the previous year, unless otherwise specified. The comparison figures for the key ratios relating to the group's results and income statement refer to the parent company Camanio Care AB (publ) (formerly Brighter Two AB), since the subsidiary Bestic AB was acquired in October 2016 and therefore the company was not a group until the last quarter of The comparison key ratios for the group for 2016 relate to the period 24/10 31/ when Camanio Care was a group. 1 OCTOBER 31 DECEMBER 2017 Net sales for the period amounted to 1,844 (1,397 ) The operating result amounted to - 5,710 (- 403 ). The result after financial items amounted to - 5,744 (- 392 ) Earnings per share were SEK ( SEK). Equity in the group at 31 December amounted to 15,769 (31/12/2016: 22,398 ) Liquid assets in the group at 31 December amounted to 5,093 (31/12/2016: 6,701 ). The liquidity amounted to 99% (31/12/2016: 296%). The equity ratio amounted to 61% (31/12/2016: 76%). The number of shares at the end of the period was 15,213,513 (31/12/2016: 10,315,592). 1 JANUARY 31 DECEMBER 2017 Net sales for the year amounted to 6,604 (3,069 for the group and 2,288 for the parent company in 2016) The operating result amounted to - 16,802 (- 4,061 for the group and - 2,845 for the parent company in 2016) The results after financial items amounted to - 16,935 (- 4,177 for the group and - 2,933 for the parent company in 2016) Earnings per share amounted to SEK ( SEK) Financial key ratios Group Quarterly Overview Quarter 1 Quarter 2 Quarter 3 Quarter 4 Acc Jan- 31 Mar 1 April- 30 June 1 July- 30 Sept 1 Oct- 31 Dec 1 Jan- 31 Dec Net sales 1,669 2, ,844 6,604 Cost of Goods ,409-3,078 EBITDA - 3,110-2,365-2,775-5,946-14,196 EBIT - 4,006-3,337-3,749-5,710-16,802 Profit/loss for the period - 4,034-3,265-3,753-5,733-16,784 Earnings per share, SEK ,38-1,29 Liquidity % 216% 286% 155% 99% 99% Equity ratio % 74% 77% 70% 61% 61% 2
3 A word from the CEO 2017 was a busy year for Camanio Care. During the year, we have worked to integrate the companies Bestic and Brighter Two and create the new company Camanio Care, which was listed on AktieTorget in March. We have also moved to a new office, acquired the Giraff product (which we have recently launched a first version of), developed the BikeAround Screen and as well as a new and simplified software version of Bestic. Today we have an efficient and competent team in place. We have a strong product portfolio that will develop a lot in the coming years, not least Giraff in connection with the EU project MoveCare. Going to the market, we can now complement our product offering with training, quality measurements and implementation support. December gave us a receipt that this work is fruitful. Several business transactions in Sweden and the USA resulted in December was the best month of the year and we ended the year with around 40% growth in total revenues. The focus for Camanio Care in 2018 is continued product development and international establishment, where the US is a prioritized market. Sweden is our important home market and this is where we have our base, where we learn in close collaboration with our customers and where we develop new solutions. North America is an important region for us and we will now strengthen our own subsidiary there in collaboration with distributors, partners and networks. Google's very well- produced film from the municipality of Tibro in Sweden has certainly sparked a growing interest. The work of establishing Camanio Care on the Chinese market has begun and there is a great deal of interest in our solutions. China is a country with tremendous potential, but there are also challenges involved in establishing the company on that market. In the rest of the world, we will continue to develop our network of distributors. We are extremely pleased that our digital telepresence robot Giraff has now taken the gigantic step from the universities to practical application in the municipalities. This is just the beginning. Healthcare will face a clear challenge in future, with more and more older people to care for at the same time as recruitment of qualified staff is challenging. Mid- February, Sverige Kommuner och Landsting (SKL) [the Swedish Association of Local Authorities and Regions] published a new report 1 on the recruitment challenges in healthcare. The report estimates that as many as 500,000 new jobs will need to be added in the next 10 years! The question is: how is this going to be done? Where will we be able to find all the staff required? At Camanio, we are convinced that new digital technology is an important piece in the puzzle in order to overcome the challenges of the future. SKL has also realized this and states that, with the aid of new technology, an annual increase in efficiency of 0.5 percent can reduce the need for recruitment by around 71,000 persons. There are many other studies along the same lines, including a report from Acreo Swedish ICT 2, which estimates the size of the annual net saving in 2020 if nine out of ten of those who receive home care services used the same four digital services that are being used in Västerås. The potential for annual savings is considerable in all the types of municipality researched. At the beginning of December, we signed an agreement on financing of up to SEK 20 million through a convertible loan with European Select Growth Opportunities Fund. The finance will take place in several "tranches" and will ensure access to capital for the company's current growth plans and international expansion. There is a great deal going on at Camanio at present and for us the last few weeks have been characterized by a number of conferences both in Sweden and abroad. There is a great deal of interest in our products and solutions, but I am also well aware of the fact that changes in the healthcare sector take time. We are breaking new ground and acceptance of the use of modern technology in health and social care is gradually increasing. Camanio is at the beginning of an exciting growth journey and I am looking forward to a successful 2018! Catharina Borgenstierna, CEO Camanio Care M. Forzati and C. Mattsson, Effekter av digitala tjänster för äldrevård: En ekonomisk studie [Effects of digital services for care of the elderly: An economic study], Acreo document no. acr057005, Stockholm,
4 Comments on the group's financial performance in the fourth quarter The group's total sales for the period October December 2017 amounted to 1,844. Total sales are higher than in the previous quarter, but they match expectations since, historically, total sales tend to be higher during the final quarter. During the corresponding period of the previous year, October December 2016, total sales of 1,397 were reported at the parent company Camanio Care AB. During the quarter, the group has had costs, primarily relating to the remaining external costs, that had an adverse effect on the operating results. The group has made an amended assessment of the goodwill post as previously reported with respect to the above value, now assessed attributable to the Balanced Development Expenses that existed in the subsidiary at the acquisition date. The goodwill has therefore been reclassified to Balanced expenses. In connection with this, the Group has also made a new assessment of the utilization period that has been assessed for 10 years, considering that it takes a long time to commercialize the products. This has resulted in lower depreciation costs in the Group. The operating result amounted to - 5,710 for the quarter. In December, the company issued a convertible loan of 4,000. Of that amount, the lender chose to convert 300 to shares in December. The remaining debt of a nominal amount of 3,700 runs up to and including A set- off issue was also carried out in November, with a debt of 2,107 being set off against shares. In total, the conversion and set- off issue led to an increase in equity of 2,693 during the period, of which 184 consisted of share capital and 2,508 consisted of a share premium. The number of subscribed shares during the period amounts to 922,481. Comments on the parent company's financial performance in the fourth quarter During the quarter, the Parent Company signed an additional agreement with Bestic AB regarding the transfer of business that occurred in With this, the Parent Company has paid an additional SEK 8,500,000 in purchase price for the business regarding the market value of the balanced development work taken over. This has been financed through a long- term loan from Bestic. Important events during the fourth quarter 11 October Camanio Care receives the remaining issue amount from the company's Chinese partner Zhongrui Funing Robotics. 12 October Camanio Care extends the product family with BikeAround Screen 18 October A press release of unaudited annual earnings figures, etc. from the Extraordinary General Meeting 19 October Issue closed and registered 24 October Camanio Care carried out a set- off issue in order to finance international sales activities 9 November We are now launching Giraff a digital telepresence robot 24 November Camanio Care Report for the quarter January September November Camanio Care carries out a business transaction involving millions in North America 6 December Camanio Care AB (publ) secures finance of up to 20 MSEK 7 December Correction of press release from 6 December 15 December Camanio Care Ab gives out free share warrants to ALL existing shareholders 18 December Increase in the number of shares in Camanio Care AB (publ) 18 December Camanio Care AB calls an Extraordinary General Meeting Important events after the end of the period 12 January Trading in share warrants series TO1 2017/2020 began on 16 January January Market notice 16/18 - Information on Camanio Care AB's share warrants 22 January A press release of unaudited annual earnings figures, etc. from an Extraordinary General Meeting 23 January Increase in the number of shares in Camanio Care AB (publ) 4
5 2 February Camanio Care has received an order from the Municipality of Hörby for the care robot Giraff 7 February Camanio signs a new distribution agreement in Canada 12 February Increase in the number of shares in Camanio Care AB (publ) Additional information This interim financial report has not been reviewed by the company's auditors. Accounting principles The group and the parent company apply the Swedish Annual Accounts Act and the general recommendations of the Swedish Accounting Standards Board "K3" (BFNAR 2012:1). The accounting principles are unchanged since the latest annual report issued. For a more detailed description of the accounting principles, see Camanio Care AB's (publ) annual report for 2016, pages THE BOARD OF DIRECTORS' PROPOSAL FOR THE APPROPRIATION OF EARNINGS The following profits in SEK are at the disposal of the Annual General Meeting: Earnings brought forward from previous years 15,977,315 Issue premium from issues during the year 14,667,766 Loss for the year - 15,274,607 Earnings at the company's disposal 15,370,469 The Board of Directors proposes that SEK 15,370,469 be carried forward to new accounts. ANNUAL GENERAL MEETING The Camanio Care AB (publ) Annual General Meeting will be held on 23 April 2018, at at the company's offices at Hästholmsvägen 32, 6tr, Nacka. The deadline for shareholders to ask to have a matter discussed at the Annual General Meeting is 16 March The annual report will be available at the time of the notice of the Annual General Meeting on the company's website, Future financial reports Date Report 23/03/ Annual Report published 23/04/ Annual General Meeting 25/05/2018 Interim Report January March /08/2018 Interim Report April June /11/2018 Interim Report July September /02/2019 Press release of unaudited annual earnings figures, etc The company's reports are published on the company's website, The reports can also be accessed via the AktieTorget website, 5
6 Income statement Group 1 Oct- 31 Dec 2017 (Group) 1 Oct- 31 Dec 2016 (Parent comp) 1 Jan- 31 Dec 2017 (Group) 1 Jan- 31 Dec 2016 (Parent comp) 24 Oct- 31 Dec 2016 (Group) Net sales 1,844 1,397 6,604 2,288 3,069 Work performed by the 48 company for its own use and capitalized Other operating revenues Total Revenue 2,224 1,397 7,279 2,305 3,153 Operating expenses Cost of goods - 1, , Other external expenses - 4,172-1,839-10,160-2,972-3,186 Personnel costs - 2, ,237-1,513-2,033 Operating profit/loss before depreciation and financial items (EBITDA) - 5, ,196-2,633-3,015 Depreciation , ,046 Operating profit/loss (EBIT) - 5, ,802-2,845-4,061 Financial items Pre- tax profit/loss - 5, ,935-2,933-4,177 Deferred tax Profit/loss for the period - 5, ,784-2,933-4,131 The profit/loss for the year is attributable to the parent company's shareholders. Parent Company 1 Oct- 31 Dec Oct- 31 Dec Jan- 31 Dec Jan- 31 Dec 2016 Net sales 1,673 1,397 6,321 2,288 Other operating revenues Total Revenue 2,054 1,397 6,996 2,305 Operating expenses Cost of goods - 1, , Other external expenses - 4,018-1,839-10,240-2,972 Personnel costs - 2, ,237-1,513 Operating profit/loss before depreciation and financial items (EBITDA) - 5, ,470-2,633 Depreciation Operating profit/loss (EBIT) - 6, ,154-2,845 Financial items Profit/loss for the period - 6, ,240-2,933 Deferred tax Profit/loss for the period - 6, ,275-2,933 6
7 Balance sheet 31/12/ /12/ /12/ /12/2016 (Group) (Group) (Parent company) (Parent company) Fixed assets Capitalised expenses 11,593 2,619 10,783 1,134 Patents, trademarks 3,153 4, Goodwill 1,275 10,374 1,275 - Equipment Participations in group ,912 14,823 companies Total fixed assets 16,459 17,519 18,958 15,972 Current assets Stocks 1, , Current receivables 3,064 4,491 3,419 4,361 Cash and bank balances 5,093 6,701 4,354 6,491 Total current assets 9,514 12,048 9,079 11,419 TOTAL ASSETS 25,973 29,567 36,501 27,391 Equity 15,769 22,398 18,483 23,596 Deferred tax liabilities Liabilities Non- current liabilities 1,274 2,445 10, Current liabilities 8,233 3,841 7,622 2,905 Total liabilities 9,507 6,286 18,018 3,795 TOTAL EQUITY AND LIABILITIES 25,973 29,567 36,501 27,391 7
8 Change in equity, Group Share capital Subscribed, non- Registered share capital Other Contributed capital Other equity including profit/loss for the year Total capital Amount at start of year 2,063 36,466-16,131 22,398 New share issues, cash 656 9,409 10,065 Issue costs, after tax Set- off issue 367 4,884 5,251 Convertible loan, stock option part Issue costs after tax Conversion to shares Repayment of shareholders' contribution - 5,555-5,555 Translation difference Profit/loss for the period - 16,784-16,784 Amount at end of period 3, ,134-38,478 15,769 Change in equity, Parent company Share capital Subscribed, unregistered share capital Share premium reserve Profit/loss brought forward Profit/loss for the year Total capital Amount at start of 2,063 30,911-6,445-2,933 23,596 year New share issues, 656 9,409 10,065 cash Issue costs after tax Set- off issue 367 4,884 5,251 Convertible loan, stock option part Issue costs after tax Conversion to shares Repayment of - 5,555-5,555 shareholders' contribution Appropriation of - 14,933 12,000 2,933 0 earnings Profit/loss for the - 15,275-15,275 period Amount at end of period 3, , ,275 18,483 8
9 Cash flow analysis 31/12/ /12/ /12/ /12/2016 (Group) (Group) (Parent company) (Parent company) Operating activities Operating profit - 16,802-4,061-15,155-2,845 Adjustment for items not 2,606 1, included in cash flow Paid/Received interest Paid income tax Cash flow from operating activities before changes in working capital - 14,356-3,109-14,558-2,721 Changes in working capital Change in inventories Change in current receivables 1, ,211 Change in current liabilities 2, , Cash flow from operating activities - 11,449-2,342-12,058-4,658 Investment activities Acquisition of intangible assets - 1, ,484-3 Acquisitions / investments in ,823 Group companies Other investment activities , ,133-14,826 Financing activities New share issue 10,189 9,424 10,239 9,395 Loan raised 8,868-18,766 14,508 Amortized loans - 2,107-1,012-1, Reimbursed / received - 5, ,555 2,565 shareholder contribution 11,395 8,412 22,053 25,924 Cash flow for the period ,138 6,440 Opening cash and cash , equivalents Exchange rate diff. in cash Closing cash and cash equivalents ,353 6,491 9
10 Our Business model Contact Camanio Care AB, Hästholmsvägen 32, Nacka Corporate ID number: About Camanio Care Camanio Care is a healthcare technology company that develops products and services focusing on the individual. The company offers solutions in robotics, assistive devices and gamification with products such as BikeAround, Bestic and Giraff. Through three focus areas; Active Life, Mealtime and Digital Care, Camanio Care wishes to support people s basic needs and increase expertise and quality in health and social care. Camanio Care has its headquarters in Stockholm, a subsidiary in the USA, as well as distributors in China, Australia and around ten European countries. Subscribe to our newsletter and learn more about the company on our website: You are welcome to follow us on: This is information that Camanio Care AB is required to publish under the EU Market Abuse Regulation. The information was provided through the above contact person for publication on 28 February This interim annual report was approved for issue by the Board of Directors on 28/02/
Interim report. Camanio Care AB
Interim report Camanio Care AB January March 2018 Summary Figures in parentheses refer to the corresponding period during the previous year, unless otherwise is stated. 1 JANUARY 31 MARCH 2018 Total Revenue
More informationInterim report. Camanio Care AB
Interim report Camanio Care AB January June 2018 Summary Figures in parentheses refer to the corresponding period during the previous year, unless otherwise is stated. 1 APRIL 30 JUNE 2018 Total revenue
More informationBioservo Technologies AB Interim Report January September 2018
Bioservo Technologies AB Interim Report January September 2018 Third quarter of 2018 in brief Net sales rose to SEK 1.0 M (0.5) EBITDA amounted to SEK -5.8 M (-3.9) EBIT totalled SEK -6.7 M (-4.5) Page
More informationOperating profit increased by 44 percent to 27.2 MSEK (19.0). Result after tax increased by 52 percent to 27.7 MSEK (18.3).
Interim report January-September 2016 November 10, 2016 Third quarter Net sales amounted to 167.0 MSEK (149.7), an increase by 11.6 percent compared to the corresponding quarter last year. At comparable
More informationInterim report January March 2009
Interim report January March 2009 Vitrolife AB (publ) Strong conclusion to a record quarter Sales increased by 22 percent to SEK 71.8 (58.7) million. Calculated in local currencies growth was 4 percent.
More informationBioservo Technologies AB Interim report, January-June 2018
Bioservo Technologies AB Interim report, January-June 2018 Second quarter of 2018 in brief Net sales rose to SEK 1.6 M (0.6) EBITDA amounted to SEK -4.0 M (-4.7) EBIT totalled SEK -4.7 M (-5.1) Bioservo
More informationInterim report. January - March First quarter January - March 2015
Interim report January - March 2015 April 28, 2015 First quarter January - March 2015 Group net sales in the first quarter 2015 amounted to 144.2 MSEK (113.7), an increase by 26.8 percent compared to the
More informationInterim report. January - September Interim report for the period January - September Third quarter July September 2014
Interim report January - September 2014 October 30, 2014 Interim report for the period January - September 2014 Third quarter July September 2014 Group net sales in the third quarter 2014 amounted to 118.5
More informationInterim report January - March First quarter. The group in brief
Interim report January - March 2017 First quarter Net sales increased by 105% to MSEK 21.1 (10.3) Operating profit declined to MSEK -4.9 (-3.3). Adjusted operating profit* increased to MSEK 1.6 (-3.3)
More informationCellaVision AB (publ) Financial Report Quarter January 1 December 31, 2006
CellaVision AB (publ) Financial Report Quarter 4 2006 January 1 December 31, 2006 Net sales increased by 49% to SEK 15.5 million (10.4) during the fourth quarter, and by 40% to SEK 54.8 million (39.0)
More informationPress Release 20 October, 2017
Press Release 20 October, 2017 Net sales increased 42.5 percent to SEK 102.0 (71.6) million (43.7 percent in local currencies) EBIT increased to SEK 40.0 (23.3) million The EBIT margin reached 39.2 (32.5)
More informationSummary of the third quarter and first nine months of 2017
Interim Report January September 2017 Evolution Gaming Group AB (publ) Third quarter of 2017 (Q3 2016) Operating revenues increased by 56% to EUR 45.7 million (29.2) EBITDA increased by 103% to EUR 21.8
More informationInterim report July September 2017
Interim report July September 2017 Significant events July September l Reinforced Group Management: Torbjörn Möller new Chief Operating Officer and Max Rydahl new marketing and sales director l British
More informationInterim report 1 January 31 March 2011
Interim report 1 January 31 March 2011 Net sales for continuing operations increased to SEK 96.7 M (85.4), up approximately 19%. Order bookings rose approximately 34% to SEK 122.9 M (96.4).* During the
More informationBiotage continues to grow with increased profitability
Interim report January-September 2018 November 6, 2018 Biotage continues to grow with increased profitability Third quarter, July - September 2018 Net sales amounted to 232.2 MSEK (177.7), which is an
More informationInvitation to subscribe for shares in Camanio Care AB
Invitation to subscribe for shares in Camanio Care AB May 2017 1 The Board of Directors is responsible for this document and has taken all reasonable measures to ensure that the information presented is
More informationInterim Report. January September Alimak Group AB ALIG, SE
ALIG, SE715891 Interim Report January September 217 For more information contact: Mathilda Eriksson, IR Manager, Phone: +46 ()8 42 14 41 Stefan Rinaldo, COO and acting CFO, Phone: +46 ()8 42 14 47 2 217
More informationInterim report January - June XVIVO Perfusion AB (publ)
Interim report January - June 2013 XVIVO Perfusion AB (publ) XVIVO Perfusion is a medical technology company which develops solutions and systems for assessing the usability of organs, allowing for treatment
More informationQUARTERLY REPORT Q3/ ANOTO
Q3/ 2014 2014 ANOTO Anoto Group AB is a global leader in digital writing solutions, which enables fast and reliable transmission of handwriting into a digital format. Anoto operates worldwide through a
More informationSmart Eye Interim Report January December 2017
Smart Eye Interim Report January December 2017 I Summary fourth quarter 2017 Net sales totalled SEK 10,506 (14,574) thousand which corresponds to a drop of 28%. Operating profit/loss totalled SEK 14,814
More informationOperating profit increased by 34 percent to 50.0 MSEK (37.2). Result after tax increased by 36 percent to 51.4 MSEK (37.7).
Interim report January - June 2018 July 16, 2018 Record figures for sales as well as operating profit Second quarter, April - June 2018 Net sales amounted to 236.1 MSEK (196.3), which is an increase by
More informationTroax Group AB (publ) Hillerstorp 13th of February, 2019
Troax Group AB (publ) Hillerstorp 13th of February, 2019 INTERIM REPORT JANUARY - DECEMBER 2018 OCTOBER - DECEMBER Order intake increased by 9 per cent to 41,7 (38,4) MEUR. Adjusted for currency the increase
More informationKey ratios Oct-Dec Oct-Dec Jan-Dec Jan-Dec
Year End Report 2010 2010 Year End Report Net sales for 2010 amounted to MSEK 212 (206). Fourth quarter net sales were MSEK 59 (64). The gross margin for 2010 was 68% (69) and the gross profit was MSEK
More informationInterim Report for First Quarter 2015
Interim Report for First Quarter First quarter The quarter began with weak order intake, which gradually improved. Order intake was 10 percent lower than in the strong first quarter of Sales volumes were
More informationINCREASED SALES AND SIGNIFICANTLY IMPROVED EARNINGS
INCREASED SALES AND SIGNIFICANTLY IMPROVED EARNINGS January September 2016 2015 Change (%) Net sales 13,030 9,770 +33 Expenses (31,325) (31,646) +1 EBITDA (11,503) (11,918) +3 EBITDA excluding legal fees
More informationINTERIM REPORT. Period from January 2018 to September Peptonic Medical AB (publ) org nr (
INTERIM REPORT Period from January 2018 to September 2018 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) 2018 THIRD QUARTER (Jul-Sep) Operating loss KSEK -3,420 (-2,969)
More informationFULL YEAR REPORT 2016
FULL YEAR REPORT 2016 THE FULL YEAR AND THE FOURTH QUARTER o Net sales amounted to MSEK 347.3 (69.1), whereof the fourth quarter MSEK 96.5 (57.4) o EBITDA was MSEK 51.7 (-71.7), whereof the fourth quarter
More informationInterim Report January-September 2009
Anoto Group Interim Report 20 Anoto Group AB is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text
More informationhms networks JANUARY - DECEMBER 2013 Fourth quarter
hms networks Y E A R - E N D R E P O R T 2 0 1 3 JANUARY - DECEMBER q Net sales for the full year reached SEK 501 m (382), corresponding to a 31 % increase. The revaluation of the Swedish currency had
More informationInterim Report January September 2018 ------------------------------------------------------------------------------------------------ July September in summary Net sales rose by about 74 percent to SEK
More informationPress release 26 October, 2018
Press release 26 October, 2018 Net sales increased 0.4 percent to SEK 217.7 (216.9) million (-2 percent in local currencies). EBIT for the year amounted to SEK 24.0 (51.9) million. The EBIT margin reached
More informationInterim report. January - September Interim report for the period January - September Third quarter, July - September 2015
Interim report January - September 2015 October 30, 2015 Interim report for the period January - September 2015 Third quarter, July - September 2015 Group net sales in the third quarter 2015 amounted to
More informationYEAR-END REPORT for the period FULL YEAR Sales increased by 12.2 % to MSEK (MSEK 657.0) EBITDA amounted to MSEK 75.0 (MSEK 75.
FULL YEAR Sales increased by 12.2 % to MSEK 737.2 (MSEK 657.0) EBITDA amounted to MSEK 75.0 (MSEK 75.5) Profit before tax increased by 1.9 % to MSEK 68.3 (MSEK 67.0) Profit margin before tax amounted to
More informationInterim Report January - March 2014
Interim Report January - March 2014 XVIVO Perfusion AB (publ) XVIVO Perfusion is a medical technology company which develops solutions and systems for assessing the usability of organs, allowing for treatment
More informationFINANCIAL INFORMATION IN BRIEF
INTERIM REPORT 1 January 30 September 2016 FINANCIAL INFORMATION IN BRIEF Third quarter: 1 July-30 September 2016 Sales for the third quarter amounted to SEK 0.6 (1.0) million. Operating result in the
More informationASSA ABLOY S INCREASED GROWTH DRIVEN BY GLOBAL TECHNOLOGIES
17 August 2005 No 10/05 ASSA ABLOY S INCREASED GROWTH DRIVEN BY GLOBAL TECHNOLOGIES Sales for the second quarter of 2005 increased organically by 6% to SEK 6,984 M (6,533) Quarterly operating income is
More informationYEAR-END REPORT JANUARY-DECEMBER 2016
YEAR-END REPORT JANUARY-DECEMBER 2016 Financial overview October December 2016 2016 2015 Change (%) Net sales 5,511 3,499 +58 Expenses (8,206) (10,790) -24 EBITDA (1,973) (2,858) +31 EBITDA adjusted for
More informationInterim report for Bactiguard Holding AB (publ) Corporate registration number
Interim report for Bactiguard Holding AB (publ) Corporate registration number 556822-1187 First quarter (January-March 2015) Revenues amounted to SEK 28.8 (34.5) million EBITDA amounted to SEK -26.8 (9.8)
More informationInterim Report. July September July- Sept. Sept
Q3 Interim Report July September Doro AB Corporate Identity Number 556161-9429 18.2% Net sales growth 8.9% EBIT margin Growth in all markets and improved margins July September Net sales amounted to SEK
More informationPress release 21 July, 2017
Press release 21 July, 2017 Net sales increased 14 percent to SEK 59.5 (52.0) million (11 percent in local currencies) EBIT decreased to SEK 6.0 (8.5) million The EBIT margin reached 10.2 (16.3) percent
More informationStrong growth profitability doubled
Year-end report January 1 December 31, 2016 Odd Molly International AB (publ) Stockholm, Sweden, February 16, 2017 Strong growth profitability doubled JANUARY 1 DECEMBER 31, 2016 Total operating revenue
More informationBoule Diagnostics AB (publ) Year-end report 2017
[Skriv här] Boule Diagnostics AB (publ) Year-end report 2017 Continued growth, increased profitability and strong cash flow Quarter October December 2017 Net sales amounted to SEK 107.2 million (104.6),
More informationC-RAD AB - INTERIM REPORT Q1
C-RAD AB - INTERIM REPORT Q1 JANUARY MARCH 2018 PRESS RELEASE APRIL 26, 2018 CONTINUED STRONG GROWTH, REVENUE INCREASED BY 31 PERCENT FIRST QUARTER 2018 Order intake: 50.6 (40.2) MSEK, 26%. Revenues: 33.8
More informationINTERIM REPORT JULY- SEPTEMBER 2018
CLAVISTER HOLDING AB (publ.) INTERIM REPORT JULY - SEPTEMBER 218 1 INTERIM REPORT JULY- SEPTEMBER 218 Clavister develops, produces and sells cybersecurity solutions. The company was founded in 1997 and
More informationBoule Diagnostics AB (publ) Interim report January September Earnings more than doubled and continued sales success
Boule Diagnostics AB (publ) Interim report January September 2016 Earnings more than doubled and continued sales success Quarter July September 2016 Net sales amounted to SEK 108.5 million (88.8), up 22.2
More informationStrong performance online, tougher in brickand-mortar
Interim report January 1 June 30, 2017 Odd Molly International AB (publ) Stockholm, Sweden August 16, 2017 Strong performance online, tougher in brickand-mortar stores APRIL 1 JUNE 30, 2017 Total operating
More informationInterim report. January - September President s comments. Third quarter. January - September
Interim report January - September Third quarter > Net sales increased by 20 percent during the third quarter to SEK 2,695 M (2,253). Net sales increased by 13 percent in local currencies. > Operating
More informationYear-end report 1 January 31 December 2011
Year-end report 1 January 31 December 2011 Net sales rose about 18%* to SEK 414 M (358). Order bookings amounted to SEK 414 M (376), up approximately 13%*. Operating profit amounted to SEK 22.6 M (22.9).
More informationVery strong license sales
Interim Report JANUARY MARCH 214 Very strong license sales License revenue for January-March increased with 27 percent to SEK 53.4 (42.) million Sales for January-March increased with 9 percent to SEK
More informationINTERIM REPORT JAN - MAR 2018
M INTERIM REPORT JAN - MAR 2018 JANUARY - MARCH Net sales increased by 12% to SEK 23.6m (21.1). Adjusted for currency exchange rate effects the increase was 20% Operating profit increased to SEK 1.8m (-4.9).
More informationYear End Report 2018
Year End Report 2018 Traffic sales had a good growth during this year Fourth quarter Net sales decreased during the fourth quarter by 23,4% to 44,1 MSEK (57,6) Result before depreciation (EBITDA) amounts
More informationIAR Systems Group AB Interim report January-June IAR Systems Group AB Interim report January-March 2017
IAR Systems Group AB Interim report January-June 217 IAR Systems Group AB Interim report January-March 217 IAR Systems Group AB Interim report January-June 217 Q1 Q2 Strong recovery in Asia and stable
More informationInvestments continue to deliver growth
SEK million Interim report January 1 June 30, 2016 Odd Molly International AB (publ) Stockholm, Sweden, August 18, 2016 Investments continue to deliver growth JANUARY 1 JUNE 30, 2016 Total operating revenue
More informationInterim report January 1 December 31, 2015 Further increase in sales and stronger profitability
Odd Molly International AB (publ) Stockholm, Sweden, February 18, 2016 Interim report January 1 December 31, 2015 Further increase in sales and stronger profitability January 1 December 31, 2015 Net sales
More informationInterim Report January March 2017
ALIG, SE715891 Interim Report January March 217 For more information contact: Per Ekstedt, CFO, Phone: +46 ()8 42 14 57 / Sofia Wretman, Head of IR, Phone: +46 ()8 42 14 41 217 - Solid performance FIRST
More informationC-RAD AB - CONSOLIDATED YEAR-END REPORT
C-RAD AB - CONSOLIDATED YEAR-END REPORT JANUARY DECEMBER 2017 PRESS RELEASE JANUARY 31, 2018 POSITIVE RESULT FOR THE FOURTH QUARTER 2017 FOURTH QUARTER 2017 Order intake: 47.5 (41.9) MSEK, +13%. Revenues:
More informationSolid underlying development in the fourth quarter
Interim Report Q4 2016 Full-year summary 2016 2 February 2017 The global leader in door opening solutions Solid underlying development in the fourth quarter Fourth quarter Sales increased by 6% to SEK
More informationYear-end Report 2016 January - December YEAR-END REPORT 2016 OCTOBER DECEMBER 2016 JANUARY DECEMBER 2016 TROAX GROUP FIGURES
Year-end Report 2016 January - December Troax Group AB (publ) Hillerstorp 14th February, 2017 YEAR-END REPORT 2016 OCTOBER DECEMBER 2016 Order intake increased by 21 per cent, or 26 per cent adjusted for
More information2.3% Interim Report. January March Good growth supported by successful launch and sales ramp-up in USA and Canada
Q1 Interim Report January March Doro AB Corporate Identity Number 556161-9429 22.3% Net sales growth 2.3% EBIT margin Good growth supported by successful launch and sales ramp-up in USA and Canada January
More informationInterim Report BE Group AB (publ) 2017 Malmö, October 24, Strongly improved underlying operating result
BE Q3 Interim Report BE Group AB (publ) Malmö, October 24, Strongly improved underlying operating result THIRD QUARTER Net sales increased by 9 percent to SEK 968 M (892), excluding operations under restructuring,
More informationInterim report. January - June Interim report for the period January - June Second quarter April - June 2013
Interim report January - June 2013 August 15, 2013 Interim report for the period January - June 2013 Second quarter April - June 2013 Group net sales in the second quarter 2013 decreased by 4.9 percent
More informationInterim Report. January September High sales growth continues with strengthened order book. July September January September 2015
Q3 Interim Report January September Doro AB Corporate Identity Number 556161-9429 34.5% Net sales growth 6.7% EBIT margin High sales growth continues with strengthened order book July September Net sales
More informationGroup net sales increased by 12 percent to MSEK (107.2). At comparable exchange rates sales increased by 8 percent.
KSEK KSEK January - March 2012 April 26, 2012 First quarter 2012 Group net sales increased by 12 percent to 119.6 MSEK (107.2). At comparable exchange rates sales increased by 8 percent. The operating
More informationNEW PRODUCT LAUNCH AND CONTINUED GROWTH IN Q1
Interim Report Nepa AB (publ) Q1 2018 NEW PRODUCT LAUNCH AND CONTINUED GROWTH IN Q1 This is a translation of the Swedish interim report. If there should be any discrepancies, the Swedish language version
More informationInterim Report January March 2018 ------------------------------------------------------------------------------------------------ First quarter in brief Net sales rose by about 30 percent to SEK 6,246k
More informationTroax Group AB (publ) Hillerstorp 8th of November, 2018
Troax Group AB (publ) Hillerstorp 8th of November, 2018 INTERIM REPORT JANUARY - SEPTEMBER 2018 JULY - SEPTEMBER Order intake increased by 14 per cent to 40,1 (35,3) MEUR. Adjusted for currency the increase
More information-3.7% 3.4% Interim Report. January December DORO GROUP (SEKm)
Q4 Interim Report January December Doro AB Corporate Identity Number 556161-9429 -3.7% Net sales development 3.4% EBIT margin Fourth quarter burdened by previously announced restructuring costs. Looking
More informationQuarterly Report Q1 2018
Quarterly Report Q1 2018 26 April 2018 The global leader in door opening solutions A good start to the year First quarter Net sales increased by 2% to SEK 18,550 M (18,142), with organic growth of 4% (6)
More informationPRECISE BIOMETRICS INTERIM REPORT JANUARY-SEPTEMBER 2017
Q3 PRECISE BIOMETRICS INTERIM REPORT JANUARY-SEPTEMBER 2017 REDUCED SALES DUE TO FEWER CUSTOMER PROJECTS INTERIM REPORT FOR THE PERIOD FROM JANUARY TO SEPTEMBER 2017 Sales dropped during the third quarter
More informationContinued good progress in all business units
Continued good progress in all business units July September The Group s sales totaled SEK 228 million (168), an increase of SEK 60 million or 36%, of which SEK 30 million was currency effects and SEK
More informationYearly. Fourth quarter YEAR-END REPORT 2018 JANUARY - DECEMBER. Net sales for the fourth quarter reached SEK 363 m (301), corresponding to an
YEAR-END REPORT JANUARY - DECEMBER Fourth quarter Net sales for the fourth quarter reached SEK 363 m (301), corresponding to an increase of 20 %. Currency translations had a positive effect of SEK 21 m
More informationYear-end report January 1 December 31, 2017
Year-end report January 1 December 31, 2017 Odd Molly International AB (publ) Stockholm, Sweden, February 16, 2018 The industry is changing - and Odd Molly with it OCTOBER 1 DECEMBER 31, 2017 Total operating
More informationMycronic AB (publ), Interim report January-March 2015
Q1 PRESS RELEASE 339E Mycronic AB (publ), Interim report January-March 2015 About Mycronic Mycronic AB is a high-tech Swedish company engaged in the development, manufacturing and marketing of production
More information2018 YEAR-END REPORT with fourth-quarter report
2016 2018 YEAR-END REPORT with fourth-quarter report Summary of the Fortnox Group for full-year 2018 (compared with the year-earlier period) Summary of the Fortnox Group for the fourth quarter of 2018
More informationSupplement to the prospectus regarding the invitation to subscribe for shares in Probi AB (publ) 2016
Supplement to the prospectus regarding the invitation to subscribe for shares in Probi AB (publ) Distribution of this Supplement and the subscription for new shares are subject to restrictions in certain
More informationP R E S S R E L E A S E
P R E S S R E L E A S E from ASSA ABLOY AB (publ) 27 April 2004 No. 5/04 ASSA ABLOY Q1: ORGANIC GROWTH AND IMPROVED MARGINS IN ALL DIVISIONS Sales in the first quarter increased organically by 3% to SEK
More informationInterim report January 1 March 31, 2016 More aggressive investments profitable growth
Odd Molly International AB (publ) Stockholm, Sweden, April 19, 2016 Interim report January 1 March 31, 2016 More aggressive investments profitable growth January 1 March 31, 2016 Net sales amounted to
More informationINTERIM REPORT 1 JANUARY 31 MARCH 2018
INTERIM REPORT 1 JANUARY 31 MARCH 2018 Growth continues 1 JANUARY 31 MARCH 2018 (3 MONTHS) Net sales rose by 4 percent to SEK 597 million (576). EBITA rose by 7 percent to SEK 57 million (54), corresponding
More informationINTERIM REPORT. January June 2018 Legres AB (publ)
INTERIM REPORT January June 2018 Legres AB (publ) Published August 29, 2018 INTERIM REPORT JANUARY JUNE 2018 SUMMARY: APRIL JUNE 2018 Net Sales amounted to SEK 199.5 million Operating Result amounted to
More informationHMS Networks AB (publ)
HMS Networks AB (publ) January December 2010 Yearend report Yearend report 2010 Net sales increased by 41 % and profit after tax increased by 200% Net sales for the year increased to SEK 344.5 m (244.5),
More informationOrganic growth in all divisions for ASSA ABLOY
Interim Report Q3 2017 20 October 2017 The global leader in door opening solutions Organic growth in all divisions for ASSA ABLOY Third quarter Net sales increased by 3% to SEK 18,499 M (18,025), with
More informationInterim report Q3 2017
Q3 Solid portfolio acquisitions and strong earnings trend July September Total revenue was unchanged at SEK 666m (665). Profit before tax increased 40 per cent to SEK 182m (130). Diluted earnings per share
More informationYrkesAkademin Fourth quarter and full year interim report 2016
YrkesAkademin Fourth quarter and full year interim report 2016 FINANCIAL OVERVIEW Fourth quarter, October-December, 2016 Net sales amounted to SEK 77.9 million (Q4 20 103.8), a decrease of 25% EBITDA amounted
More informationHalf year report January-June 2015
Heliospectra AB (publ) Half year report January-June 2015 Heliospectra AB (publ) Half Year Report Jan-June 2015, page 1/9 Important events January-March A first order worth SEK 1 million from growers in
More informationInvestments and adaptations for the future one-off costs impacting the result
Interim report January 1 September 30, 2017 Odd Molly International AB (publ) Stockholm, Sweden, October 24, 2017 Investments and adaptations for the future one-off costs impacting the result JULY 1 SEPTEMBER
More informationYrkesAkademin First quarter 2018
YrkesAkademin First quarter 2018 FINANCIAL OVERVIEW First quarter, January March 2018 Net sales increased 64% from last year s first quarter to SEK 149.1 million (Q1 2017: 90.6) EBITDA was SEK 17.8 million
More informationAxis achieves profitability
Interim Report January September 2001 Axis achieves profitability Group sales for comparable units during the first nine months amounted to SEK 487 M (440). Total sales, including Netch, which was divested
More informationPRESS RELEASE Observer AB is quoted on the Attract 40 section of Stockholmsbörsen s O-list and has approximately 25,000 shareholders.
PRESS RELEASE Observer AB is quoted on the Attract 40 section of Stockholmsbörsen s O-list and has approximately 25,000 shareholders. Observer AB (publ) Year-end report January December 2003 The Nordic
More informationKnowit AB Interim Report
... Knowit AB Interim Report January march 2013... Highlights... Continued weak market Results and margin on par with the fourth quarter 2012 Strong growth in the public sector, but weaker in Finance and
More informationINTERIM REPORT 1 JANUARY 31 MARCH 2018
INTERIM REPORT 1 JANUARY 31 MARCH 2018 Quarterly period January-March Poolia s revenue amounted to SEK 200.4 (199.2) million. Operating profit amounted to SEK 4.8 (7.0) million, with an operating margin
More informationYear-end report (1 Jan-31 Dec 2007) Continued improved results for Doro - Core business profitable and strong growth in Care Electronic
Year-end report (1 Jan-31 Dec 2007) Continued improved results for Doro - Core business profitable and strong growth in Care Electronic Fourth quarter 2007 Sales amounted to SEK 114 million (SEK 121 m)
More informationΔ Δ. Sales, SEK M 19,484 20,109 3% 71,293 76,137 7%
Quarterly Report Q4 2017 Full-year summary 2017 6 February 2018 The global leader in door opening solutions A strong finish to 2017 Fourth quarter Net sales increased by 3% to SEK 20,109 M (19,484), with
More informationINTERIM REPORT 1 JANUARY 31 MARCH 2017
INTERIM REPORT 1 JANUARY 31 MARCH 2017 Quarterly period January-March Reported revenue, earnings, cash flow and financial ratios relate to continuing operations, and do not include Poolia UK. Poolia s
More informationGroup in Summary MEUR % % Revenue % %
Handicare Group AB (publ) Torshamnsgatan 35, SE-164 40 Kista Sweden Tel: +46 8 523 281 00 Corp. Reg. No.: 556982-7115 www.handicaregroup.com Year-end report 2017 Continued organic growth and improved margins
More informationInterim Report January March 2017
Interim Report January March 2017 Prestige order for Fabege s project Grand Central Sundyberg First quarter of 2017 ChromoGenics received a large order to deliver approximately 550m 2 of dynamic glass
More informationhms networks First quarter Last twelve months INTERIM REPORT 2017 JANUARY - MARCH
hms networks INTERIM REPORT JANUARY - MARCH Last twelve months Net sales for the last twelve months amounted to SEK 1 030 m (732) corresponding to a 37 % increase in local currencies. The revaluation of
More informationCONTINUED GROWTH AND STRATEGIC ACQUISITION
LUND, FEBRUARY 14, 2017 CONTINUED GROWTH AND STRATEGIC ACQUISITION PRECISE BIOMETRICS AB (PUBL), CORPORATE IDENTITY NO. 556545-6596 YEAR-END REPORT 2016 FOURTH QUARTER Consolidated net sales increased
More informationInterim report January 1 March 31, 2015 A strong quarter with increased growth and higher profitability
Odd Molly International AB (publ) Stockholm, Sweden, April 29 april, 2015 SEKM 380 360 340 320 300 280 260 240 220 200 Rolling 12 months sales quarterly sales Q2 2010 - Q1 2015 Q1-11 Q1-12 Q1-13 Q1-14
More informationInterim report 1 January 31 March 2018 Actic Group AB
Q1 Interim report 1 January 31 March Actic Group AB Efficiency enhancements and acquisitions strengthen results INTERIM REPORT 1 JANUARY 31 MARCH ACTIC GROUP AB 1 Interim report 1 January 31 March First
More informationStrong growth at Nolato Medical
Nolato three-month interim report 2007, page 1 of 11 Nolato AB (publ) three-month interim report 2007 Strong growth at Nolato Medical First quarter 2007 in brief Sales totaled SEK 560 M (594) The acquisition
More information